Medullary cystic kidney disease
A group of autosomal dominant tubulointerstitial nephropathies characterized by slowly progressive chronic kidney disease with a bland urinary sediment (little blood/protein), normal-to-small kidneys (± few late medullary/corticomedullary cysts), and histology showing tubular atrophy and interstitial fibrosis. Modern nomenclature groups these conditions as ADTKD, subclassified by gene (most often UMOD, MUC1, REN, HNF1B; rarer SEC61A1, DNAJB11, APOA4). “Medullary cystic kidney disease (MCKD)” (types 1 & 2) corresponds largely to ADTKD‑MUC1 and ADTKD‑UMOD, and is a misnomer because cysts are not required for diagnosis.
- Often mislabeled as “CKD of unknown cause,” ADTKD leads to ESRD in mid‑to‑late adulthood (median ~40s–50s depending on subtype) and is under‑recognized on exams and in clinic. Early recognition guides family screening, avoids unnecessary workups/biopsies, explains early gout (UMOD/REN), and prompts appropriate counseling (excellent transplant outcomes; disease usually does not recur in the graft).
- Common thread: autosomal‑dominant family history of CKD across generations, minimal proteinuria, bland urine, slowly rising creatinine beginning in the teens–30s.
- ADTKD‑UMOD (formerly MCKD2/FJHN): hyperuricemia with early gout (often teens/20s), impaired urinary concentration (polyuria/nocturia), normal‑to‑small kidneys with few cysts; CKD progression over decades.
- ADTKD‑MUC1 (formerly MCKD1): isolated kidney disease—no consistent extrarenal features; bland urine, CKD beginning in late teens/20s; cysts may be absent or few; many standard sequencing panels miss MUC1 (specialized testing needed).
- ADTKD‑REN: childhood presentation with hypotension, anemia, mild hyperkalemia & metabolic acidosis, salt craving/polyuria; later hyperuricemia ± gout; AD family history.
- ADTKD‑HNF1B (RCAD): kidney disease with renal cysts/dysplasia plus MODY5 diabetes, hypomagnesemia, and GU/pancreatic/hepatic anomalies; variable course.
- When to suspect ADTKD: AD family history of CKD + bland urine (protein <~500 mg/day) + normal/small kidneys (± few medullary/corticomedullary cysts).
- First steps: urinalysis (often bland), serum uric acid (high in UMOD/REN), renal ultrasound (often normal early; later small kidneys ± few cysts).
- Genetic testing: order an inherited kidney disease panel including UMOD, MUC1, REN, HNF1B. Note: MUC1 frameshift variants are hard to detect with routine NGS/Sanger; targeted assays or immunostaining for MUC1fs may be required at specialized labs.
- Biopsy? Not diagnostic alone (nonspecific tubulointerstitial fibrosis/TA, thickened/lamellated TBM; microcysts). Use it mainly to exclude other etiologies.
- Subtype clues: early gout → UMOD/REN; childhood anemia/hyperkalemia/hypotension → REN; extrarenal features (MODY5, GU malformations, low Mg) → HNF1B; isolated CKD with negative routine panels → MUC1.
| Condition | Distinguishing Feature |
|---|---|
| Autosomal dominant polycystic kidney disease (ADPKD) | Numerous cysts with enlarged kidneys and more proteinuria; extrarenal cysts (liver); different genes (PKD1/2). |
| Nephronophthisis (AR) | Pediatric AR ciliopathy with polyuria/polydipsia, corticomedullary cysts, early ESRD; extrarenal features in syndromic forms. |
| Medullary sponge kidney | Congenital collecting duct dilation with nephrocalcinosis and stones; kidney function often preserved; not an inherited AD tubulointerstitial disease. |
| Chronic interstitial nephritis (e.g., analgesics, lithium) | History of drug exposure; may have sterile pyuria, WBC casts; no autosomal‑dominant pattern. |
- No disease‑modifying therapy yet—CKD care (BP control, RAAS blockade as tolerated, avoid nephrotoxins, treat acidosis, manage anemia/mineral bone disease).
- Gout/hyperuricemia (UMOD/REN/HNF1B): allopurinol or febuxostat for flares/prevention; discuss risks (hypersensitivity; pregnancy considerations). Avoid meds that raise urate (e.g., high‑dose thiazides) when possible.
- ADTKD‑REN: consider fludrocortisone and liberal salt intake to address hypotension/hyperkalemia; treat childhood anemia per CKD practice (± EPO).
- HNF1B (RCAD): manage MODY5 diabetes, monitor/treat hypomagnesemia and other extrarenal issues.
- Transplantation: excellent outcomes; recurrence in the allograft is not expected for UMOD/MUC1/REN subtypes.
- MCKD is a misnomer—you can have ADTKD without visible cysts; kidneys are often normal or small, not massively cystic (contrast with ADPKD).
- UMOD = uric acid & gout (think “U‑ric acid”). REN = REnin pathway → childhood anemia, hyperkalemia, hypotension. MUC1 = MUC‑h else normal (isolated kidney disease).
- Urine is boringly bland (little protein/hematuria) despite worsening CKD—this is a classic exam clue.
- Transplant works well—disease typically does not recur in the graft.
- Early‑onset gout (teens/20s) with a family history of CKD → think ADTKD‑UMOD.
- Child with CKD + anemia + mild hyperkalemia + low BP in a dominant pedigree → concerning for ADTKD‑REN.
- “CKD of unknown cause” with bland urine and normal/small kidneys across generations—do not miss ADTKD; refer for genetic testing.
- Suspect inherited tubulointerstitial disease → confirm AD family history and bland urine (low protein/hematuria).
- Renal ultrasound → normal/small kidneys ± few medullary/corticomedullary cysts.
- Order genetic testing panel (UMOD, MUC1, REN, HNF1B; add SEC61A1/DNAJB11 if available). If panel negative but suspicion high → arrange MUC1‑specific testing.
- Subtyping guides anticipatory care: UMOD/REN (urate/gout), REN (child anemia/hypotension/hyperkalemia), HNF1B (RCAD features).
- Manage per CKD guidelines; treat gout; fludrocortisone for ADTKD‑REN hypotension/hyperkalemia. Consider transplant when advanced.
- Teen with recurrent gout and a father/uncle on dialysis; UA with trace/no protein, ultrasound shows small kidneys with few or no cysts → ADTKD‑UMOD.
- Child with fatigue, anemia, mild hyperkalemia, low‑normal BP, polyuria; parent with CKD in 30s–40s → ADTKD‑REN.
- Adult with CKD stage 3, bland urine, normal‑size kidneys (no significant cyst burden), negative UMOD/HNF1B/REN on panel; specialized testing confirms MUC1 frameshift → ADTKD‑MUC1.
- Don’t confuse with ADPKD: huge cystic kidneys, numerous cysts, higher proteinuria; or medullary sponge kidney: nephrocalcinosis, stones, often normal kidney function.
A 22‑year‑old man has recurrent podagra and a father who started dialysis at 48.
A 7‑year‑old boy has fatigue, **anemia**, mild **hyperkalemia**, low‑normal BP, nocturia, and a mother with CKD.
A 35‑year‑old woman with slowly rising creatinine since age 24; urine is bland; imaging shows normal‑sized kidneys without many cysts. Her father required transplant at 52.

Public‑domain Gray’s Anatomy diagram of a nephron (tubules and collecting system in cortex/medulla), the compartment affected in ADTKD.
Gray’s Anatomy (1918), Public Domain — via Wikimedia Commons🔗 Knowledge Map
📚 References & Sources
- 1StatPearls — Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD)
- 2GeneReviews — ADTKD‑MUC1 (historically MCKD1)
- 3KDIGO Consensus Report — ADTKD: diagnosis, classification & management (Kidney Int. 2015)
- 4MedlinePlus Genetics — ADTKD‑UMOD
- 5Kidney International — Clinical and genetic spectra of ADTKD (Olinger et al., 2020)
- 6Merck Manual Professional — Nephronophthisis and ADTKD (overview & contrasts)
- 7NIDDK — Medullary Sponge Kidney (for differential)
